Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment
Open Access
- 17 October 2023
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (10) , 2483
Abstract
Silencing genes using small interfering (si) RNA is a promising strategy for treating cancer. However, the curative effect of siRNA is severely constrained by low serum stability and cell membrane permeability. Therefore, improving the delivery efficiency of siRNA for cancer treatment is a research hotspot. Recently, mesoporous silica nanoparticles (MSNs) have emerged as bright delivery vehicles for nucleic acid drugs. A comprehensive understanding of the design of MSN-based vectors is crucial for the application of siRNA in cancer therapy. We discuss several surface-functionalized MSNs’ advancements as effective siRNA delivery vehicles in this paper. The advantages of using MSNs for siRNA loading regarding considerations of different shapes, various options for surface functionalization, and customizable pore sizes are highlighted. We discuss the recent investigations into strategies that efficiently improve cellular uptake, facilitate endosomal escape, and promote cargo dissociation from the MSNs for enhanced intracellular siRNA delivery. Also, particular attention was paid to the exciting progress made by combining RNAi with other therapies to improve cancer therapeutic outcomes.Keywords
Funding Information
- National Natural Science Foundation of China (82074027, 82104405, LZ21H280001, LY23H300002)
- Natural Science Foundation of Zhejiang Province (82074027, 82104405, LZ21H280001, LY23H300002)
This publication has 146 references indexed in Scilit:
- Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivoNanoscale, 2013
- TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivoBlood, 2013
- A mesoporous silica nanoparticle – PEI – Fusogenic peptide system for siRNA delivery in cancer therapyBiomaterials, 2013
- Efficient Functional Delivery of siRNA using Mesoporous Silica Nanoparticles with Ultralarge PoresSmall, 2012
- Delivery of Small Interfering RNA by Peptide-Targeted Mesoporous Silica Nanoparticle-Supported Lipid BilayersACS Nano, 2012
- Enhanced Cancer Immunotherapy Using STAT3-Depleted Dendritic Cells with High Th1-Inducing Ability and Resistance to Cancer Cell-Derived Inhibitory FactorsThe Journal of Immunology, 2011
- Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid TumorsCancer Research, 2011
- Co‐delivery of Doxorubicin and Bcl‐2 siRNA by Mesoporous Silica Nanoparticles Enhances the Efficacy of Chemotherapy in Multidrug‐Resistant Cancer CellsSmall, 2009
- Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stabilityCancer Immunology, Immunotherapy, 2008
- Exploiting the enhanced permeability and retention effect for tumor targetingDrug Discovery Today, 2006